ArticleJournal of nanobiotechnology2026

Targeting microglial circMBNL1 unlocks a novel nanomedicine therapeutic strategy for major depressive disorder.

Xiaoyu Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.